Was the Plexus (PLXS) CEO’s share sale part of a Rule 10b5-1 plan?

Yes. The filing states that the 1,500-share sale by President & CEO Todd P. Kelsey was made pursuant to a Rule 10b5-1 trading plan adopted on November 20, 2025, indicating the trades were pre-arranged rather than timed at management’s discretion.

Plexus (NASDAQ: PLXS) CEO sells 1,500 shares under 10b5-1 plan

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Plexus Corp President & CEO Todd P. Kelsey reported an open-market sale of 1,500 shares of common stock. The shares were sold on April 15, 2026 at a weighted average price of $224.0867 per share. Following this transaction, he directly holds 80,291 shares of Plexus common stock.

The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 20, 2025, and occurred through multiple trades within a price range of $223.98 to $224.30 per share.

Insider Trade Summary 10b5-1

Net Seller: 1,500 shares ($336,130)

Net Sell 1 txn

Insider Kelsey Todd P.

Role President & CEO

Sold 1,500 shs ($336K)

Type	Security	Shares	Price	Value
Sale	Common Stock, $.01 par value	1,500	$224.0867	$336K

Holdings After Transaction: Common Stock, $.01 par value — 80,291 shares (Direct)

Footnotes (1)

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025. This transaction was executed in multiple trades at prices ranging from $223.98 to $224.30 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares sold: 1,500 shares Weighted average sale price: $224.0867 per share Post-transaction holdings: 80,291 shares +3 more

6 metrics

Shares sold 1,500 shares Open-market sale on April 15, 2026

Weighted average sale price $224.0867 per share Common stock sale on April 15, 2026

Post-transaction holdings 80,291 shares Shares directly owned after the sale

Price range of trades $223.98–$224.30 per share Multiple executions comprising the reported sale

Trading plan adoption date November 20, 2025 Rule 10b5-1 plan governing this sale

Net shares sold 1,500 shares Net selling activity in this Form 4

Key Terms

Rule 10b5-1 plan, weighted average sale price, open-market sale, Common Stock, $.01 par value

4 terms

Rule 10b5-1 plan regulatory

"Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025."

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

weighted average sale price financial

"The reported price reflects the weighted average sale price."

open-market sale financial

"transaction_action: "open-market sale" for 1,500 shares of common stock."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock, $.01 par value financial

"security_title: "Common Stock, $.01 par value" in the transaction record."

Form 4 Insider Transactions: What Each Field Means →

04/16/2026 - 04:55 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kelsey Todd P.

(Last)

(First)

(Middle)

ONE PLEXUS WAY

(Street)

NEENAH

WISCONSIN

54956

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PLEXUS CORP [ PLXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, $.01 par value	04/15/2026		S⁽¹⁾		1,500	D	$224.0867⁽²⁾	80,291	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

2. This transaction was executed in multiple trades at prices ranging from $223.98 to $224.30 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

	/s/ Todd P. Kelsey, by Kate A. Gitter, Attorney-in-Fact	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Plexus Corp (PLXS) disclose for Todd P. Kelsey?

Plexus Corp reported that President & CEO Todd P. Kelsey executed an open-market sale of 1,500 shares of common stock. The transaction occurred on April 15, 2026, and was carried out under a pre-arranged Rule 10b5-1 trading plan adopted in November 2025.

At what price did the Plexus (PLXS) CEO sell shares and how many?

Todd P. Kelsey sold 1,500 Plexus common shares at a weighted average price of $224.0867 per share. The sale was completed in multiple trades within a price range of $223.98 to $224.30, as disclosed in the Form 4 footnotes.

How many Plexus (PLXS) shares does Todd P. Kelsey hold after this Form 4 sale?

After the reported transaction, Todd P. Kelsey directly holds 80,291 shares of Plexus common stock. This figure reflects his position immediately following the April 15, 2026 open-market sale of 1,500 shares disclosed in the Form 4 filing.

How was the reported sale price for the Plexus (PLXS) Form 4 transaction calculated?

The reported sale price of $224.0867 per share is a weighted average across multiple trades. These trades were executed at prices ranging from $223.98 to $224.30 per share, and the insider has undertaken to provide detailed trade data upon request.